Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
|Title||Drug Target Insights|
|Abbreviation||Drug Target Insights|
|Subject Area, Categories, Scope||Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)|
|SCImago Journal Rank (SJR)||0.690|
|Coverage History||2008-2009, 2011-2022|
Drug Target Insights is a journal covering the technologies/fields/categories related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2). It is published by AboutScience Srl. The overall rank of Drug Target Insights is 7236. According to SCImago Journal Rank (SJR), this journal is ranked 0.690. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 15. The best quartile for this journal is Q1.
The ISSN of Drug Target Insights journal is 11773928. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Target Insights is cited by a total of 62 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Drug Target Insights is 2.80, which is computed in 2023 as per its definition. Drug Target Insights IF is increased by a factor of 0.2 and approximate percentage change is 7.69% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Drug Target Insights is 2.80. If the same upward trend persists, Impact IF may rise in 2023 as well.
Drug Target Insights has an h-index of 15. It means 15 articles of this journal have more than 15 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Drug Target Insights is 11773928. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Drug Target Insights is 7236. According to SCImago Journal Rank (SJR), this journal is ranked 0.690. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Drug Target Insights is published by AboutScience Srl. It's publishing house is located in Italy. Coverage history of this journal is as following: 2008-2009, 2011-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Drug Target Insights is Drug Target Insights. This abbreviation ('Drug Target Insights') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Drug Target Insights latest impact IF is 2.80. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.23 (2015) and 1.83 (2016), respectively, in the last 9 years. Moreover, its average IS is 2.43 in the previous 9 years.
The Drug Target Insights has an SJR (SCImago Journal Rank) of 0.690, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.845 in 2015 and the lowest being 0.297 in 2020. Furthermore, the average SJR of the Drug Target Insights over the previous 9-year period stands at 2.43.
The latest h-index of the Drug Target Insights is 15.
The Drug Target Insights is published by the AboutScience Srl, with its country of publication being the Italy.
The Drug Target Insights is currently ranked 7236 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 5511 in 2015 and its lowest position of 14926 in 2020.
The standard ISO4 abbreviation for the Drug Target Insights is Drug Target Insights.
Drug Target Insights is classified as a journal that the AboutScience Srl publishes.
The Drug Target Insights encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Drug Target Insights is assigned the following International Standard Serial Numbers (ISSN): 11773928.
The best quartile for the Drug Target Insights is Q1 (2022).
The Drug Target Insights coverage history can be summarized as follows: 2008-2009, 2011-2022.
|Journal/Conference/Workshop/Book Title||Type||Ranking||Publisher||h-index||Impact Score|
|Historia||journal||27560||Universidade Estadual Paulista||7||0.02|
|Journal of Field Archaeology||journal||5639||Maney Publishing||43||2.38|
|Proceedings of the ASME Turbo Expo||conference and proceedings||17577||54||0.00|
|Air and Space Power Journal (discontinued)||journal||28397||AU Press||9||0.20|
|Libyan Studies||journal||16122||Cambridge University Press||8||0.45|
|Asian Textile Journal||trade journal||27455||G P S Kwatra||10||0.01|
|Journal des Professionnels de l'Enfance||journal||27577||TPMA||2||0.00|
|Genes and Nutrition||journal||6154||BioMed Central Ltd.||61||3.28|
|Proteomics - Clinical Applications||journal||9140||Wiley-VCH Verlag||59||2.02|
|European Journal of Cancer, Supplement||journal||9063||Elsevier Ltd.||28||1.93|
|Year||Impact Score (IS)|